An Irony

An irony of the drug reimportation debate:

Proponents of drug reimportation often say they are merely trying to make prescription drugs more affordable for American seniors, but the pro-drug reimportation stance of the House is so strongly opposed by the Senate that the provision is a major (though, to be fair, not the sole) complicating factor working against passage of a Medicare prescription drug benefit this year.

In related news, Ed Haislmaier’s work exposing the dangers of drug reimportation continues apace, with the Houston Chronicle and Charlotte Observer, among others, running his thoughts on their op-ed pages.

The National Center for Public Policy Research is a communications and research foundation supportive of a strong national defense and dedicated to providing free market solutions to today’s public policy problems. We believe that the principles of a free market, individual liberty and personal responsibility provide the greatest hope for meeting the challenges facing America in the 21st century.